RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Standard BioTools Stock

Standard BioTools Equity 2024

Standard BioTools Equity

163.2 M USD

Ticker

LAB

ISIN

US34385P1084

WKN

A0RADJ

In 2024, Standard BioTools's equity was 163.2 M USD, a -28.98% increase from the 229.8 M USD equity in the previous year.

Standard BioTools Aktienanalyse

What does Standard BioTools do?

Fluidigm Corp is a biotechnology company specializing in innovative devices and solutions for DNA sequencing. The company was founded in 1999 in San Francisco and is currently headquartered in South San Francisco. It developed the Microfluidic Technology-Sensor, which allows for handling tiny amounts of fluids in a small space. This technology has enabled researchers to analyze complex samples and collect data with high accuracy. The company operates in two main segments: Analytical Instruments and Sample Preparation. In the Analytical Instruments segment, Fluidigm offers various devices suitable for DNA sequencing, including the Juno, C1, and Biomark platforms. It also provides a wide range of consumables to facilitate sample preparation. The Sample Preparation segment offers products and services to prepare and process samples for analysis, including microfluidic technology chips and modules, single-cell sequencing systems, and products for next-generation sequencing. Fluidigm serves customers in various industries, such as genomics research, cancer research, and medical fields, with a strong presence in North America, Europe, and Asia. The company is known for its continuous investment in research and development, as well as its innovative technologies and patents. Overall, Fluidigm's Microfluidic technology platform allows researchers to collect data in a small space with high accuracy. With a diversified portfolio of products and services, the company is well-positioned to continue growing and expanding its market presence in the coming years. Standard BioTools ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Standard BioTools's Equity

Standard BioTools's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Standard BioTools's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Standard BioTools's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Standard BioTools's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Standard BioTools’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Standard BioTools stock

What is the equity of Standard BioTools this year?

Standard BioTools has equity of 163.2 M USD this year.

What was the equity of Standard BioTools compared to the previous year?

The equity of Standard BioTools has increased/decreased by -28.98% decreased compared to the previous year.

What impact does a high equity have on investors of Standard BioTools?

A high equity is advantageous for investors of Standard BioTools as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Standard BioTools?

A low equity can be a risk for investors of Standard BioTools, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Standard BioTools affect the company?

An increase in equity of Standard BioTools can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Standard BioTools affect the company?

A reduction in equity of Standard BioTools can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Standard BioTools?

Some factors that can affect the equity of Standard BioTools include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Standard BioTools so important for investors?

The equity of Standard BioTools is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Standard BioTools take to change the equity?

To change equity, Standard BioTools can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Standard BioTools pay?

Over the past 12 months, Standard BioTools paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Standard BioTools is expected to pay a dividend of 0 USD.

What is the dividend yield of Standard BioTools?

The current dividend yield of Standard BioTools is .

When does Standard BioTools pay dividends?

Standard BioTools pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Standard BioTools?

Standard BioTools paid dividends every year for the past 0 years.

What is the dividend of Standard BioTools?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Standard BioTools located?

Standard BioTools is assigned to the 'Health' sector.

Wann musste ich die Aktien von Standard BioTools kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Standard BioTools from 8/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/11/2024.

When did Standard BioTools pay the last dividend?

The last dividend was paid out on 8/11/2024.

What was the dividend of Standard BioTools in the year 2023?

In the year 2023, Standard BioTools distributed 0 USD as dividends.

In which currency does Standard BioTools pay out the dividend?

The dividends of Standard BioTools are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Standard BioTools stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Standard BioTools

Our stock analysis for Standard BioTools Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Standard BioTools Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.